AAAAAA
Results: 26-50/52
Authors:
Ryan, PJ
Blake, GM
Davie, M
Haddaway, M
Gibson, T
Fogelman, I
Citation: Pj. Ryan et al., Intermittent oral disodium pamidronate in established osteoporosis: A 2 year double-masked placebo-controlled study of efficacy and safety, OSTEOPOR IN, 11(2), 2000, pp. 171-176
Authors:
Blake, GM
Herd, RJM
Patel, R
Fogelman, I
Citation: Gm. Blake et al., The effect of weight change on total body dual-energy X-ray absorptiometry: Results from a clinical trial, OSTEOPOR IN, 11(10), 2000, pp. 832-839
Authors:
Patel, R
Blake, GM
Rymer, J
Fogelman, I
Citation: R. Patel et al., Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women, OSTEOPOR IN, 11(1), 2000, pp. 68-75
Authors:
Cook, GJR
Lodge, MA
Blake, GM
Marsden, PK
Fogelman, I
Citation: Gjr. Cook et al., Differences in skeletal kinetics between vertebral and humeral bone measured by F-18-fluoride positron emission tomography in postmenopausal women, J BONE MIN, 15(4), 2000, pp. 763-769
Authors:
Rea, JA
Chen, MB
Li, J
Blake, GM
Steiger, P
Genant, HK
Fogelman, I
Citation: Ja. Rea et al., Morphometric X-ray absorptiometry and morphometric radiography of the spine: A comparison of prevalent vertebral deformity identification, J BONE MIN, 15(3), 2000, pp. 564-574
Authors:
Cook, GJR
Blake, GM
Fogelman, I
Citation: Gjr. Cook et al., The time of day that Etidronate is ingested does not influence its therapeutic effect in osteoporosis, SC J RHEUM, 29(1), 2000, pp. 62-64
Authors:
Fogelman, I
Herd, RJM
Blake, GM
Balena, R
Citation: I. Fogelman et al., Cyclical etidronate therapy for prevention of postmenopausal bone loss: A 1-year open-label follow-up study, CALCIF TIS, 66(5), 2000, pp. 348-354
Authors:
Fogelman, I
Blake, GM
Citation: I. Fogelman et Gm. Blake, Different approaches to bone densitometry, J NUCL MED, 41(12), 2000, pp. 2015-2025
Authors:
Fogelman, I
Davey, V
Ochs, HD
Elashoff, M
Feinberg, MB
Mican, J
Siegel, JP
Sneller, M
Lane, HC
Citation: I. Fogelman et al., Evaluation of CD4(+) T cell function in vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization, J INFEC DIS, 182(2), 2000, pp. 435-441
Authors:
Fogelman, I
Ribot, C
Smith, R
Ethgen, D
Sod, E
Reginster, JY
Citation: I. Fogelman et al., Risedronate reverses bone loss in postmenopausal women with low bone mass:Results from a multinational, double-blind, placebo-controlled trial, J CLIN END, 85(5), 2000, pp. 1895-1900
Authors:
Ravn, P
Weiss, SR
Rodriguez-Portales, JA
McClung, MR
Wasnich, RD
Gilchrist, NL
Sambrook, P
Fogelman, I
Krupa, D
Yates, AJ
Daifotis, A
Fuleihan, GE
Citation: P. Ravn et al., Alendronate in early postmenopausal women: Effects on bone mass during long-term treatment and after withdrawal, J CLIN END, 85(4), 2000, pp. 1492-1497
Authors:
Cook, GJR
Fogelman, I
Citation: Gjr. Cook et I. Fogelman, Diagnostic nuclear medicine, CANCER AND THE SKELETON, 2000, pp. 91-111
Authors:
Cook, GJR
Fogelman, I
Citation: Gjr. Cook et I. Fogelman, Diagnosis and monitoring of bone metastases: Scintigraphy, TUMOR BONE DISEASES AND OSTEOPOROSIS IN CANCER PATIENTS, 2000, pp. 131-154
Authors:
Buckler, H
Fraser, W
Hosking, D
Ryan, W
Maricic, MJ
Singer, F
Davie, M
Fogelman, I
Birbara, CA
Moses, AM
Lyles, K
Selby, P
Richardson, P
Seaman, J
Zelenakas, K
Siris, E
Citation: H. Buckler et al., Single infusion of zoledronate in Paget's disease of bone: A placebo-controlled, dose-ranging study, BONE, 24(5), 1999, pp. 81S-85S
Authors:
Patel, R
Blake, GM
Fogelman, I
Citation: R. Patel et al., Radiation dose to the patient and operator from a peripheral dual X-ray absorptiometry system, J CLIN DENS, 2(4), 1999, pp. 397-401
Authors:
Fogelman, I
Citation: I. Fogelman, Screening for osteoporosis - No point until we have resolved issues about long term treatment, BR MED J, 319(7218), 1999, pp. 1148-1149
Authors:
Rea, JA
Chen, MB
Li, J
Potts, E
Fan, B
Blake, GM
Steiger, P
Smith, IG
Genant, HK
Fogelman, I
Citation: Ja. Rea et al., Morphometric X-ray absorptiometry and morphometric radiography of the spine: A comparison of analysis precision in normal and osteoporotic subjects, OSTEOPOR IN, 9(6), 1999, pp. 536-544
Authors:
Blake, GM
Preston, NG
Patel, R
Herd, RJM
Fogelman, I
Citation: Gm. Blake et al., An unexpected change in DXA calibration not detected by routine quality control checks, OSTEOPOR IN, 9(2), 1999, pp. 115-120
Authors:
Frost, ML
Blake, GM
Fogelman, I
Citation: Ml. Frost et al., Contact quantitative ultrasound: An evaluation of precision, fracture discrimination, age-related bone loss and applicability of the WHO criteria, OSTEOPOR IN, 10(6), 1999, pp. 441-449
Authors:
Cook, GJR
Lodge, MA
Marsden, PK
Dynes, A
Fogelman, I
Citation: Gjr. Cook et al., Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions, EUR J NUCL, 26(11), 1999, pp. 1424-1429
Authors:
Cook, GJR
Maisey, MN
Fogelman, I
Citation: Gjr. Cook et al., Normal variants, artefacts and interpretative pitfalls in PET imaging with18-fluoro-2-deoxyglucose and carbon-11 methionine, EUR J NUCL, 26(10), 1999, pp. 1363-1378
Authors:
Jacobson, AF
Fogelman, I
Citation: Af. Jacobson et I. Fogelman, Skeletal scintigraphy in breast and prostate cancer: Past, present, and future, NUCL MED A, 1999, pp. 121-156
Authors:
Cook, GJR
Fogelman, I
Citation: Gjr. Cook et I. Fogelman, Skeletal metastases from breast cancer: Imaging with nuclear medicine, SEM NUC MED, 29(1), 1999, pp. 69-79
Authors:
Patel, R
Blake, GM
Jefferies, A
Sautereau-Chandley, PM
Fogelman, I
Citation: R. Patel et al., A comparison of a peripheral DXA system with conventional densitometry of the spine and femur, J CLIN DENS, 1(3), 1998, pp. 235-244
Authors:
Blake, GM
Patel, R
Fogelman, I
Citation: Gm. Blake et al., Peripheral or axial bone density measurements?, J CLIN DENS, 1(1), 1998, pp. 55-63